Utility of Multiparametric CT for Identification of High-Risk NAFLD

被引:17
|
作者
Lubner, Meghan G. [1 ]
Graffy, Peter M. [1 ]
Said, Adnan [2 ]
Watson, Rao [3 ]
Zea, Ryan [4 ]
Malecki, Kyle M. [1 ]
Pickhardt, Perry J. [1 ]
机构
[1] Univ Wisconsin, Dept Radiol, Sch Med & Publ Hlth, E3-311 Clin Sci Ctr,600 Highland Ave, Madison, WI 53792 USA
[2] Univ Wisconsin, Div Hepatol, Dept Internal Med, Sch Med & Publ Hlth, Madison, WI USA
[3] Univ Wisconsin, Dept Internal Med, Sch Med & Publ Hlth, Madison, WI USA
[4] Univ Wisconsin, Dept Biostat, Sch Med & Publ Hlth, Madison, WI USA
关键词
CT; hepatic fibrosis; liver; NAFLD; nonalcoholic fatty liver disease; FATTY LIVER-DISEASE; MAGNETIC-RESONANCE ELASTOGRAPHY; SURFACE NODULARITY QUANTIFICATION; LONG-TERM OUTCOMES; HEPATIC STEATOSIS; UNENHANCED CT; NONALCOHOLIC STEATOHEPATITIS; DIAGNOSTIC PERFORMANCE; NONINVASIVE ASSESSMENT; ADVANCED FIBROSIS;
D O I
10.2214/AJR.20.22842
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The purpose of this study was to evaluate the utility of laboratory and CT metrics in identifying patients with high-risk nonalcoholic fatty liver disease (NAFLD). MATERIALS AND METHODS. Patients with biopsy-proven NAFLD who underwent CT within 1 year of biopsy were included. Histopathologic review was performed by an experienced gastrointestinal pathologist to determine steatosis, inflammation, and fibrosis. The presence of any lobular inflammation and hepatocyte ballooning was categorized as nonalcoholic steatohepatitis (NASH). Patients with NAFLD and advanced fibrosis (stage F3 or higher) were categorized as having high-risk NAFLD. Aspartate transaminase to platelet ratio index and Fibrosis-4 (FIB-4) laboratory scores were calculated. CT metrics included hepatic attenuation, liver segmental volume ratio (LSVR), splenic volume, liver surface nodularity score,and selected texture features. In addition, two readers subjectively assessed the presence of NASH (present or not present) and fibrosis (stages F0-F4). RESULTS. A total of 186 patients with NAFLD (mean age, 49 years; 74 men and 112 women) were included. Of these, 87 (47%) had NASH and 112 (60%) had moderate to severe steatosis. A total of 51 patients were classified as fibrosis stage F0, 42 as F1, 23 as F2, 37 as F3, and 33 as F4. Additionally, 70 (38%) had advanced fibrosis (stage F3 or F4) and were considered to have high-risk NAFLD. FIB-4 score correlated with fibrosis (ROC AUC of 0.75 for identifying high-risk NAFLD). Of the individual CT parameters, LSVR and splenic volume performed best (AUC of 0.69 for both for detecting high-risk NAFLD). Subjective reader assessment performed best among all parameters (AUCs of 0.78 for reader 1 and 0.79 for reader 2 for detecting high-risk NAFLD). FIB-4 and subjective scores were complementary (combined AUC of 0.82 for detecting high-risk NAFLD). For NASH assessment, FIB-4 performed best (AUC of 0.68), whereas the AUCs were less than 0.60 for all individual CT features and subjective assessments. CONCLUSION. FIB-4 and multiple CT findings can identify patients with high-risk NAFLD (advanced fibrosis or cirrhosis). However, the presence of NASH is elusive on CT.
引用
收藏
页码:659 / 668
页数:10
相关论文
共 50 条
  • [1] Should We Screen High-Risk Populations for NAFLD?
    Caussy C.
    Current Hepatology Reports, 2019, 18 (4) : 433 - 443
  • [2] Head to head comparison between MEFIB versus MAST for identification of high-risk patients with NAFLD
    Kim, Beom Kyung
    Tamaki, Nobuharu
    Jung, Jinho
    Sutter, Nancy
    Sirlin, Claude
    Nakajima, Atsushi
    Loomba, Rohit
    JOURNAL OF HEPATOLOGY, 2022, 77 : S422 - S422
  • [3] The Utility of Symptoms in Identification of Primary Angle-Closure in a High-Risk Population
    Ong, Ee Lin
    Baasanhu, Jamyanjav
    Nolan, Winifred
    Uranchimeg, Davatsuren
    Lee, Pak-Sang
    Alsbirk, Poul Helge
    Johnson, Gordon J.
    Foster, Paul J.
    OPHTHALMOLOGY, 2008, 115 (11) : 2024 - 2029
  • [4] THE IDENTIFICATION OF HIGH-RISK POPULATIONS
    LIPKIN, M
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1984, 19 : 91 - 97
  • [5] IDENTIFICATION OF THE HIGH-RISK GRAVIDA
    PETRES, RE
    COOGAN, EM
    MEDICAL COLLEGE OF VIRGINIA QUARTERLY, 1980, 16 (1-2): : 4 - 8
  • [6] IDENTIFICATION OF HIGH-RISK NEWBORNS
    VELICKOVIC, M
    ZDRAVSTVENI VESTNIK, 1983, 52 (12): : 555 - 558
  • [7] IDENTIFICATION OF HIGH-RISK LABORS
    ODRISCOLL, K
    BRITISH MEDICAL JOURNAL, 1975, 3 (5976): : 157 - 157
  • [8] IDENTIFICATION OF HIGH-RISK PREGNANCY
    GILES, HR
    ARIZONA MEDICINE, 1974, 31 (11) : 839 - 840
  • [9] IDENTIFICATION OF HIGH-RISK LABORS
    STUDD, J
    BRITISH MEDICAL JOURNAL, 1975, 3 (5985): : 702 - 702
  • [10] Identification of high-risk pregnancies
    Thoulon, JM
    CONTRACEPTION FERTILITE SEXUALITE, 1998, 26 (02): : I - V